- Home
- CATX vs INNV Comparison
CATX vs INNV Comparison
Compare CATX & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CATX | INNV |
|---|---|---|
| Founded | 1983 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 211.1M | 485.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | CATX | INNV |
|---|---|---|
| Price | $2.80 | $5.52 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 9 | 1 |
| Target Price | ★ $11.56 | $5.00 |
| AVG Volume (30 Days) | ★ 1.5M | 184.4K |
| Earning Date | 11-10-2025 | 02-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,075,000.00 | ★ $884,662,000.00 |
| Revenue This Year | N/A | $11.18 |
| Revenue Next Year | N/A | $9.58 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 12.48 |
| 52 Week Low | $1.60 | $2.60 |
| 52 Week High | $5.39 | $6.26 |
Technical Indicators
Market Signals| Indicator | CATX | INNV |
|---|---|---|
| Relative Strength Index (RSI) | 57.16 | 53.38 |
| Support Level | $2.45 | $5.66 |
| Resistance Level | $2.90 | $6.10 |
| Average True Range (ATR) | 0.21 | 0.36 |
| MACD | 0.05 | 0.03 |
| Stochastic Oscillator | 85.37 | 62.07 |
Price Performance
Historical ComparisonAbout CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
About INNV InnovAge Holding Corp.
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.